According to data from the CDC, BQ.1 and BQ.1.1 now make up the largest share of new COVID-19 infections.
Health officials are worried about immunocompromised and organ transplant patients because several antibody treatments that they relied on don’t work on the latest versions of the virus.
Early laboratory tests show that the new subvariants are better at escaping vaccines and booster shots than previous variants.
Read the full article here.